Table 2.
Study Groups | No. Tested (%) |
No. Positive (%) |
Control Groups | No. Tested (%) |
No. Positive (%) |
Normotensives | 0(0.0) | 0(0.0) | Normotensives | 5(100.0) | 1(20.0) |
Hypertensives | 20(30.8) | 8(40.0) | Hypertensives | 0(0.0) | 0(0.0) |
Hypertensive Heart failure |
4(6.2) | 1(25.0) | Hypertensive Heart failure | 0(0.0) | 0(0.0) |
Dilated Cardiomyopathy | 41(63.1) | 26(63.4) | Dilated Cardiomyopathy | 0(0.0) | 0(0.0) |
Total | 65(100.0) | 35 (53.8) | Total | 5(100.0) | 1 (20.0) |